Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002007 Hualan Biological Engineering, Inc.
- 16.18
- +0.65+4.19%
Market Closed Apr 1 15:00 CST
29.59BMarket Cap27.19P/E (TTM)
16.24High15.55Low228.90KlotVolume15.57Open15.53Pre Close367.51MTurnover1.46%Turnover Ratio27.19P/E (Static)1.83BShares19.9852wk High2.49P/B25.46BFloat Cap13.7252wk Low17.08Limit Up1.57BShs Float74.90Historical High13.98Limit Down4.44%Amplitude-2.28Historical Low0.30Dividend TTM16.06Avg Price76.56KlotAsk1.85%Div YieldTTM100Lot Size147.65KlotBid
Hualan Biological Engineering, Inc. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -2.77%4.93B | 1.44%3.55B | -5.94%2.3B | 4.53%1.15B | 22.45%5.08B | 31.51%3.5B | 43.47%2.44B | 35.51%1.1B | -9.40%4.14B | -18.12%2.66B |
| Refunds of taxes and levies | 90,704.30%10.76M | 1,334.93%309.65K | 1,334.93%309.65K | ---- | 23.35%11.85K | 159.67%21.58K | 5,313.66%21.58K | ---- | 11,350.33%9.61K | --8.31K |
| Cash received relating to other operating activities | -6.62%68.05M | -6.92%54.33M | -11.82%31.46M | 35.29%18.58M | 39.52%72.87M | 27.48%58.37M | 22.52%35.67M | 16.59%13.73M | -40.41%52.23M | -35.31%45.79M |
| Cash inflows from operating activities | -2.62%5.01B | 1.31%3.61B | -6.02%2.33B | 4.90%1.17B | 22.66%5.15B | 31.44%3.56B | 43.12%2.48B | 35.24%1.12B | -9.98%4.2B | -18.48%2.71B |
| Goods services cash paid | 6.44%1.66B | 24.55%1.55B | 34.82%927.58M | 75.97%530.41M | 21.60%1.56B | 12.57%1.25B | -14.44%688.03M | -22.00%301.42M | 4.34%1.28B | 22.08%1.11B |
| Staff behalf paid | 3.98%478.49M | -3.91%337.39M | 5.47%254.22M | 8.88%144.15M | 4.05%460.19M | 3.04%351.13M | 2.53%241.02M | 0.72%132.4M | 4.39%442.27M | 5.74%340.78M |
| All taxes paid | 0.22%505.02M | -0.29%342.01M | 7.51%236.35M | 44.60%145.76M | 10.19%503.91M | -2.48%343.01M | 32.72%219.84M | 18.13%100.8M | -19.06%457.3M | -12.77%351.74M |
| Cash paid relating to other operating activities | 2.51%1.31B | -1.29%914.26M | 4.96%588.18M | 41.18%302.25M | 20.89%1.28B | 16.28%926.24M | 9.05%560.38M | 29.79%214.09M | 4.50%1.06B | -1.32%796.56M |
| Cash outflows from operating activities | 3.99%3.95B | 9.75%3.15B | 17.38%2.01B | 49.93%1.12B | 17.36%3.8B | 10.42%2.87B | -0.55%1.71B | -2.53%748.71M | 0.30%3.24B | 6.42%2.6B |
| Net cash flows from operating activities | -21.29%1.06B | -33.63%459.71M | -58.13%321.34M | -86.41%50.19M | 40.59%1.35B | 521.05%692.62M | 6,440.70%767.38M | 531.54%369.23M | -33.17%957.31M | -87.36%111.52M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 268.86%23.64B | 321.86%17.9B | 269.76%11.74B | 34.58%2.07B | -38.93%6.41B | -51.94%4.24B | -41.94%3.17B | -4.65%1.54B | -21.68%10.49B | -17.63%8.83B |
| Cash received from returns on investments | 53.84%135.29M | 127.23%141.92M | 142.01%116.22M | 102.35%50.53M | 27.65%87.94M | -27.57%62.46M | -2.78%48.02M | 28.24%24.97M | -45.58%68.89M | -17.31%86.23M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.56%892.59K | -99.62%769.07K | -99.66%690.24K | -99.78%441.21K | 305.60%204.11M | 294.84%203.33M | 295.00%203.15M | 107,649.99%203.11M | 5,435.96%50.32M | 24,702.25%51.5M |
| Net cash received from disposal of subsidiaries and other business units | --1.55M | --1.55M | --7.03K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 254.84%23.77B | 300.19%18.05B | 246.07%11.86B | 20.10%2.12B | -36.87%6.7B | -49.72%4.51B | -38.48%3.43B | 8.16%1.77B | -21.54%10.61B | -17.16%8.97B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -66.10%255.43M | -14.33%457.43M | -29.71%260.39M | -39.63%110.36M | 91.25%753.41M | 171.09%533.95M | 146.05%370.43M | 27.42%182.79M | -51.45%393.95M | -59.18%196.96M |
| Cash paid to acquire investments | 237.35%23.43B | 288.44%17.57B | 219.66%10.42B | -10.57%2.08B | -45.18%6.94B | -55.89%4.52B | -48.10%3.26B | -3.58%2.32B | -12.47%12.67B | -4.45%10.25B |
| Cash paid relating to other investing activities | --362.32K | ---- | --362.32K | --162.32K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 207.65%23.68B | 256.47%18.03B | 194.23%10.68B | -12.68%2.19B | -41.07%7.7B | -51.61%5.06B | -43.55%3.63B | -1.84%2.5B | -14.54%13.06B | -6.80%10.45B |
| Net cash flows from investing activities | 109.02%90.08M | 103.38%18.54M | 669.42%1.17B | 91.30%-64.14M | 59.25%-998.28M | 63.06%-547.89M | 76.22%-205.61M | 19.65%-737.13M | -39.30%-2.45B | -281.56%-1.48B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -66.13%16.28M | --16.28M | --16.28M | ---- | -97.87%48.07M | ---- | ---- | ---- | --2.25B | --2.25B |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.25B | --2.25B |
| Cash from borrowing | -14.79%596.47M | -50.00%300M | -50.00%300M | --200M | -36.36%700M | 0.00%600M | 100.00%600M | ---- | -15.38%1.1B | -45.45%600M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200M |
| Cash inflows from financing activities | -18.09%612.75M | -47.29%316.28M | -47.29%316.28M | --200M | -77.70%748.07M | -80.36%600M | -76.51%600M | ---- | 158.06%3.35B | 177.71%3.05B |
| Borrowing repayment | 16.67%700M | -58.33%250M | -75.00%150M | ---- | -40.00%600M | -25.47%600M | 11,900.00%600M | ---- | 42.86%1B | 101.25%805M |
| Dividend interest payment | -2.85%585.45M | -1.98%586.91M | -2.13%582.72M | 33.33%6.28M | 41.64%602.65M | 42.45%598.77M | 47.09%595.41M | -46.93%4.71M | -24.58%425.48M | -24.34%420.33M |
| -Including:Cash payments for dividends or profit to minority shareholders | 201.56%117.62M | 200.00%117.01M | 200.00%117.01M | ---- | 50.00%39M | 50.00%39M | 50.00%39M | ---- | --26M | --26M |
| Cash payments relating to other financing activities | 28,195.58%107.74M | 28,046.16%107.17M | --39.13M | --380.75K | -96.64%380.75K | --380.75K | ---- | ---- | --11.33M | ---- |
| Cash outflows from financing activities | 15.81%1.39B | -21.27%944.08M | -35.43%771.85M | 41.41%6.66M | -16.27%1.2B | -2.14%1.2B | 191.70%1.2B | -46.93%4.71M | 13.66%1.44B | 28.24%1.23B |
| Net cash flows from financing activities | -71.54%-780.43M | -4.78%-627.8M | 23.49%-455.56M | 4,204.00%193.34M | -123.72%-454.96M | -132.75%-599.15M | -127.76%-595.41M | -100.21%-4.71M | 5,244.03%1.92B | 1,166.29%1.83B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -182.77%-52.41K | -53,875.68%-45.95K | -639.53%-97.15K | -76,077.80%-99.05K | 27.25%63.32K | -100.17%-85.14 | -42.31%18.01K | 92.12%-130.03 | 246.97%49.76K | 1,662.57%49.63K |
| Net increase in cash and cash equivalents | 443.74%368.94M | 67.08%-149.59M | 3,183.40%1.04B | 148.12%179.28M | -125.24%-107.33M | -199.30%-454.43M | -102.60%-33.61M | -126.87%-372.61M | 246.43%425.29M | -28.29%457.66M |
| Add:Begin period cash and cash equivalents | -9.79%989.32M | -9.79%989.32M | -9.79%989.32M | -9.79%989.32M | 63.35%1.1B | 63.35%1.1B | 63.35%1.1B | 63.35%1.1B | -30.20%671.37M | -30.20%671.37M |
| End period cash equivalent | 37.29%1.36B | 30.75%839.73M | 90.56%2.03B | 61.40%1.17B | -9.79%989.32M | -43.12%642.22M | -45.86%1.06B | -64.82%724.04M | 63.35%1.1B | -29.44%1.13B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.